NCT05409157View on ClinicalTrials.gov

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

October 15, 2022

Study Completion Date

October 15, 2022

Conditions
Healthy Participants
Interventions
DRUG

BMS-986166

Specified dose on specified days

DRUG

Bisacodyl

Specified dose on specified days

Trial Locations (1)

53704-2526

Local Institution - 0001, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05409157 - A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants | Biotech Hunter | Biotech Hunter